Provided by Tiger Fintech (Singapore) Pte. Ltd.

Royalty Pharma plc

34.84
-0.4300-1.22%
Post-market: 34.860.0190+0.05%18:52 EDT
Volume:3.53M
Turnover:123.05M
Market Cap:14.68B
PE:14.21
High:35.38
Open:35.09
Low:34.72
Close:35.27
Loading ...

4 Stocks With Growth Potential That Recently Announced Dividend Hikes

Zacks
·
22 Jan

Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now

Insider Monkey
·
16 Jan

Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To $0.22

Simply Wall St.
·
13 Jan

Here’s Why Royalty Pharma plc (RPRX) Led This Week’s Rally

Insider Monkey
·
13 Jan

Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher?

Insider Monkey
·
12 Jan

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires Live
·
11 Jan

Royalty Pharma Up Nearly 8%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
11 Jan

Unusually active option classes on open January 10th

TIPRANKS
·
10 Jan

Royalty Pharma Shares up 6.3% After Co Simplifies Corporate Structure With $1.1 Bln Deal

THOMSON REUTERS
·
10 Jan

Sector Update: Health Care Stocks Decline Premarket Friday

MT Newswires Live
·
10 Jan

BUZZ-Royalty Pharma rises on $1.1 bln deal to acquire its external manager

Reuters
·
10 Jan

Royalty Pharma Shares up 5.8% Premarket After Co Simplifies Corporate Structure With $1.1 Bln Deal

THOMSON REUTERS
·
10 Jan

Royalty Pharma to Acquire Managing Company for $1.1 Billion in Cash, Equity; Authorizes $3 Billion Share Buyback

MT Newswires Live
·
10 Jan

BRIEF-Royalty Pharma To Highlight Accomplishments And Provide Business Update At 43rd Annual J.P. Morgan Healthcare Conference

Reuters
·
10 Jan

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
10 Jan

Royalty Pharma simplifies corporate structure with $1.1 bln deal

Reuters
·
10 Jan

Royalty Pharma Plc - Intends to Repurchase $2 Billion of Shares in 2025

THOMSON REUTERS
·
10 Jan

Royalty Pharma Plc - Deal Terms Include 24.5 Mln Shares of Royalty Pharma Equity That Will Vest Over 5-9 Years, $100 Mln Cash, $380 Mln Debt

THOMSON REUTERS
·
10 Jan

Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of Its External Manager and $3 Billion Share Repurchase Program

THOMSON REUTERS
·
10 Jan

Royalty Pharma Plc - Expected Cash Savings of $1.6 Billion Over Ten Years

THOMSON REUTERS
·
10 Jan